NEW YORK, March 8, 2017 /PRNewswire/ -- l metabolomics
market is projected to reach USD 2.39
billion by 2021, at a CAGR of 14.6% during the forecast
period of 2016 to 2021. The metabolomics market has witnessed
significant growth primarily due to the increasing need for
accurate diagnosis of diseases, rising demand for personalized
medicine, and emergence of advanced technologies.
Read the full report:
http://www.reportlinker.com/p04763096-summary/view-report.html
In this report, the global metabolomic market is segmented by
product and service, application, indication, and region. Based on
product and service, this market is further segmented into two
major segments—metabolomics instruments and metabolomics
bioinformatics tools & services. Based on metabolomics
instruments, the market is further segmented into detection tools
and separation tools. The separation tools segment commanded the
largest share in the global metabolomics instruments market in
2015. The large share of this segment can be attributed to the ease
of separation, characterization of metabolites, and quantitation of
chemical compounds achieved by separation tools such as UPLC.
Based on application, the market is segmented into biomarker
discovery, drug discovery, nutrigenomics, toxicology testing,
personalized medicine, functional genomics, and others. In 2015,
the biomarker discovery segment accounted for the largest share of
the global metabolomics market. The personalized medicine segment
is expected to register the highest CAGR during the forecast period
due to collaborations between pharmaceutical companies and
biotechnology firms for biomarker discovery and validation.
In 2015, North America commanded
the largest share of the metabolomics market, followed by
Europe. The U.S. is the prime
market for metabolomics due to the rising acceptance of
personalized medicines and growing focus of stakeholders on
research projects involving metabolites, amino acid composition,
and associated biomolecules in the country. The Asia-Pacific market is expected to witness the
highest growth in the coming years primarily due to the growing
focus of manufacturers on this region.
Major players in the global metabolomics market are Agilent
Technologies, Inc. (U.S.), Bruker Corporation (U.S.), Danaher
Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Shimadzu
Corporation (Japan), Waters
Corporation (U.S.) Bio-Rad Laboratories (U.S.), Biocrates Life
Sciences AG (Austria), Human
Metabolome Technologies Inc. (Japan), LECO Corporation (U.S.), and Metabolon
Inc. (U.S.).
Research Coverage
- Detailed insights on all the submarkets, based on metabolomics
instruments (Gas Chromatography, Capillary Electrophoresis,
High-performance Liquid Chromatography, Ultra-performance Liquid
Chromatography, Nuclear Magnetic Resonance Spectroscopy, Mass
Spectrometry, and Surface-based Mass Analysis), this can help
market players to identify high growth segments in the metabolomics
market.
- The report also provides information on key players in this
market and their growth strategies and recent developments. This
can help the company to assess the competition at global and
regional levels in a better manner.
- Key insights and market sizing for the different end users of the
metabolomics market namely, hospitals, laboratories, academic
institutes, biotechnology firms, clinical research laboratories,
and other end users.
- Country-wise market size and forecast for all the subsegments.
Thus, not only the high growth product & service, technology,
application, and indication areas; the market size numbers provided
in the report will also enable players to identify key geographic
markets, and thereby strategize global marketing efforts in order
to achieve sustainable revenue growth in the coming years.
- It provides key insights on market dynamics, such as drivers,
restraints, opportunities, and challenges for this market.
Reasons to Buy the Report
The report will enrich established firms as well as new
entrants/smaller firms to gauge the pulse of the market, which in
turn would help them garner a greater market share. Firms
purchasing the report could use one or a combination of the
below-mentioned five strategies for increasing their market
shares.
This report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product
portfolios offered by top players in the metabolomics market. The
report analyzes the market by product & service, application,
and indication
- Product Development/Innovation: Detailed insights on upcoming
trends, R&D activities, and new product launches in the
metabolomics market
- Market Development: Comprehensive information on lucrative
emerging markets, based on product & service, application,
indication, and region
- Market Diversification: Exhaustive information about new
products, growing regions, recent developments, and investments in
the metabolomics market
- Competitive Assessment: In-depth assessment of market shares,
growth strategies, products, distribution networks, and
manufacturing capabilities of leading players in the metabolomics
market
Read the full report:
http://www.reportlinker.com/p04763096-summary/view-report.html
About Reportlinker
ReportLinker is an award-winning market research solution.
Reportlinker finds and organizes the latest industry data so you
get all the market research you need - instantly, in one place.
http://www.reportlinker.com
__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/metabolomics-market-by-product-application-indication---forecast-to-2021-300420625.html
SOURCE Reportlinker